Cis-regulation of EGFR in glioblastoma

NIH RePORTER · NIH · F30 · $50,520 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT Glioblastoma is the most common primary intrinsic brain tumor and universally lethal. Like many other cancers, glioblastomas have recurrent focal amplifications of oncogenes that promote cancer growth. It is not known to what extent other constituents of these amplicons support tumor formation. Cis-regulatory elements, including enhancers, are vital to the transcriptional regulation of many genes and may be an underappreciated part of these amplicons. I now propose to study the role of cis-regulatory elements in the regulation of EGFR, a very commonly amplified oncogene in glioblastoma. To accomplish this goal, I will use a CRISPR interference (CRISPRi) strategy to selectively repress putative enhancers at the EGFR locus and assess their role in EGFR regulation and overall cancer cell growth phenotype. Secondly, I will use chromosome conformation capture strategies to uncover how the looping of cis-regulatory elements in focal amplifications contributes to EGFR expression. Collectively, these proposed studies will provide a more general basis for how the cis-regulatory landscape is utilized by oncogenes in focal amplifications.

Key facts

NIH application ID
9971338
Project number
5F30CA236313-02
Recipient
CASE WESTERN RESERVE UNIVERSITY
Principal Investigator
Andrew Robert Morton
Activity code
F30
Funding institute
NIH
Fiscal year
2020
Award amount
$50,520
Award type
5
Project period
2019-07-01 → 2021-06-30